|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/14 | |
| A61K 38/00 | |||
| A61K 38/48 |
| (11) | Patento numeris | 2222315 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08864646.8 |
| Europos patento paraiškos padavimo data | 2008-12-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-09-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-04-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/087031 |
| Data | 2008-12-16 |
| (87) | Numeris | WO 2009/082648 |
| Data | 2009-07-02 |
| (30) | Numeris | Data | Šalis |
| 16230 P | 2007-12-21 | US |
| (72) |
MANKARIOUS, Samia, US
GRIFFITH, Michael, J., US
|
| (73) |
Cangene Corporation,
115 Innovation Drive, Winnipeg, Manitoba R3T 5Y3,
CA
|
| (54) | STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE |
| STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE |